Available Forms: Tablets
Available Strengths: 5 mg, 10 mg, 23 mg
Reference Brands: Aricept (USA/EU)
Category: Neurology
Quick Response Guaranteed | Verified Suppliers
Product Description:
Donepezil Hydrochloride is a piperidine derivative and a centrally acting, rapid, and reversible acetylcholinesterase inhibitor primarily used in the treatment of Alzheimer’s disease. It works by inhibiting acetylcholinesterase, the enzyme responsible for breaking down acetylcholine after its release at synaptic junctions. By reversibly binding to this enzyme, donepezil prevents acetylcholine hydrolysis, leading to increased availability of acetylcholine at synapses and enhanced cholinergic neurotransmission in the brain. This mechanism supports improved communication between nerve cells involved in memory and cognition. Donepezil Hydrochloride is approved by the U.S. Food and Drug Administration for the treatment of mild, moderate, and severe dementia associated with Alzheimer’s disease. While it does not alter the underlying progression of the disease, it has demonstrated clinical benefit in alleviating symptoms by improving cognitive function, behavior, and daily functioning in affected individuals. In addition to its approved indication, donepezil is also utilized in various off-label clinical applications. The medication is administered orally and requires appropriate monitoring for adverse effects, drug interactions, and patient response. Donepezil Hydrochloride remains a cornerstone therapy in the symptomatic management of Alzheimer’s disease in clinical practice.
Donepezil Hydrochloride is used to treat mild, moderate, and severe Alzheimer’s disease by improving cognitive function, memory, and the ability to perform daily activities.
Donepezil Hydrochloride is a piperidine-based compound that acts as a reversible inhibitor of acetylcholinesterase, increasing acetylcholine levels in the brain.
The most common trade name is Aricept®, along with several regional brand names worldwide.
Donepezil Hydrochloride is manufactured by multiple pharmaceutical companies globally, including the originator company Eisai for Aricept® and various generic manufacturers.
The generic name is Donepezil Hydrochloride.
Brand names include Arice® and other country-specific brands and generics.
Donepezil Hydrochloride is manufactured in several countries including the USA, EU, India, and other regions, depending on the manufacturer.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under ‘Fair use.’
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online · B2B Pharma · Medical Tourism · NPP